Corrigendum: Substrate Fragmentation for the Design of M.âtuberculosis CYP121 Inhibitors.

Kavanagh, Madeline E; Gray, Janine L; Gilbert, Sophie H; Coyne, Anthony G; McLean, Kirsty J; Davis, Holly J; Munro, Andrew W; Abell, Chris

Corrigendum: Substrate Fragmentation for the Design of M.âtuberculosis CYP121 Inhibitors.

Kavanagh, Madeline E; Gray, Janine L; Gilbert, Sophie H; Coyne, Anthony G; McLean, Kirsty J; Davis, Holly J; Munro, Andrew W; Abell, Chris.

ChemMedChem ; 12(2): 194-195, 2017 01 20.

Article en En | MEDLINE | ID: mdl-28112499

Palabras clave

drug discovery; enzymes; fragment-based methods; substrate analogues; tuberculosis

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886599
https://dx.doi.org/10.1002/cmdc.201600619

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2017 Tipo del documento: Article